- Healthpeak and Janus Living priced an upsized IPO of 42 million shares of Janus Living Class A-1 common stock at USD 20 per share.
- Janus Living granted underwriters a 30-day option to buy up to 6.3 million additional shares at the IPO price.
- The Class A-1 shares are expected to begin trading on the NYSE under the ticker JAN on March 20, 2026.
- After the IPO, Healthpeak is expected to own about 214.73 million Janus Living shares, representing an 83.6% voting interest.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Healthpeak Properties Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202603191635BIZWIRE_USPR_____20260319_BW051897) on March 19, 2026, and is solely responsible for the information contained therein.